Prophylactic dressing
A medical dressing is described for prevention of pressure ulcers. The dressing has a gel pad having a low compressive strength; i.e. from 5 kPa to 60 kPa at a strain of 50%, as measured by the compression test described herein. The dressing reduces the shear and compression forces on the skin and in the underlying the soft tissue layers and prevents or mitigates the onset of pressure ulcers.
1. A medical dressing configured to be applied on intact skin and configured to prevent an onset of a pressure ulcer during use, wherein the medical dressing has a first side and a second opposing side, wherein the first side has a skin-facing surface adapted to detachably adhere the medical dressing to a dermal surface; the medical dressing comprising a gel pad arranged between a backing layer and an adhesive body contact layer, wherein the adhesive body contact layer comprises the skin-facing surface of the first side, wherein the adhesive body contact layer comprises a silicone based adhesive,
wherein at least the backing layer extends beyond the periphery of the gel pad to define a border portion around a contour of the gel pad,
wherein a gel of the gel pad has a compressive strength of from 5 to 60 kPa at a strain of 50%, as measured according to a compression test, wherein the gel pad is configured to prevent the onset of the pressure ulcer during use,
wherein the gel pad, the backing layer, and the adhesive body contact layer are substantially transparent,
wherein the substantial transparency of the gel pad, the backing layer, and the adhesive body contact layer in combination with the compressive strength of the gel of the gel pad allows a caregiver to perform a blanching test through the medical dressing of an area of a subject covered by the gel pad, the backing layer, and the adhesive body contact layer during use.
2. The medical dressing configured to be applied on intact skin and configured to prevent an onset of a pressure ulcer during use according to claim 1 , wherein the medical dressing has a lateral (x) extension and a longitudinal (y) extension; the pad being symmetric about a longitudinal center line and the medical dressing comprising a first lobed portion on one side of the longitudinal center line and a second lobed portion on the other side of the longitudinal center line.
3. The medical dressing configured to be applied on intact skin and configured to prevent an onset of a pressure ulcer during use according to claim 2 , wherein an anisotropic layer is arranged such that a first direction (x) of the anisotropic layer corresponds to the lateral (x) extension of the dressing, and a second direction (y) of the anisotropic layer corresponds to the longitudinal extension of the dressing, wherein the anisotropic layer is arranged between the gel pad and the adhesive body contact layer.
4. The medical dressing configured to be applied on intact skin and configured to prevent an onset of a pressure ulcer during use according to claim 2 , wherein the medical dressing is divided into three separate zones along the longitudinal (y) extension of the medical dressing: one central zone and two lateral zones, wherein the gel pad in at least the central zone comprises a plurality of indentations.
5. The medical dressing configured to be applied on intact skin and configured to prevent an onset of a pressure ulcer during use according to claim 2 , wherein the medical dressing is divided into three separate zones along the longitudinal (y) extension of the dressing: one central zone and two lateral zones, wherein a compressive strength of the gel of the gel pad in the central zone is lower than in the lateral zones.
6. The medical dressing configured to be applied on intact skin and configured to prevent an onset of a pressure ulcer during use according to claim 1 , wherein the gel of the gel pad has a compressive strength from 1 to 14 kPa at a strain of 25%, as measured according to the compression test.
7. The medical dressing configured to be applied on intact skin and configured to prevent an onset of a pressure ulcer during use according to claim 1 , wherein the gel of the gel pad has a compressive strength of from 5 to 40 kPa at a strain of 50%, as measured according to the compression test.
8. The medical dressing configured to be applied on intact skin and configured to prevent an onset of a pressure ulcer during use according to claim 1 , wherein the gel of the gel pad is manufactured by polymerizing:
15-50% by weight of a hydrophilic acrylic monomer;
50-85% by weight of a hydrophilic softening agent;
0.001-0.5% by weight of a crosslinker; and
0.05-0.5% by weight of a polymerization initiator.
9. The medical dressing configured to be applied on intact skin and configured to prevent an onset of a pressure ulcer during use according to claim 1 , wherein the gel pad has an opacity of less than 25% as measured by a opacity test.
10. The medical dressing configured to be applied on intact skin and configured to prevent an onset of a pressure ulcer during use according to claim 1 , wherein the medical dressing comprises an anisotropic layer having a first direction (x) and a second direction (y), wherein a tensile force at 15% strain of the anisotropic layer is higher in the second direction (y than in the first direction (x), when measured according to a tensile test, wherein the anisotropic layer is arranged between the gel pad and the adhesive body contact layer.
11. The medical dressing configured to be applied on intact skin and configured to prevent an onset of a pressure ulcer during use according to claim 10 , wherein the tensile force at 15% strain of the anisotropic layer in the second direction (y) is at least 6 times higher than in the first direction (x), when measured according to the tensile test.
12. The medical dressing configured to be applied on intact skin and configured to prevent an onset of a pressure ulcer during use according to claim 1 , wherein the medical dressing comprises at least one gripping tab.
13. A method comprising:
a) applying the medical dressing configured to be applied on intact skin and configured to prevent an onset of a pressure ulcer during use accordingly to claim 1 to a subject at an area of risk of developing a pressure ulcer, thereby reducing the risk of the development of a pressure ulcer at the area of risk of developing a pressure ulcer.
14. The medical dressing configured to be applied on intact skin and configured to prevent an onset of a pressure ulcer during use according to claim 1 , wherein the adhesive body contact layer is perforated.
15. The medical dressing configured to be applied on intact skin and configured to prevent an onset of a pressure ulcer during use according to claim 1 , wherein the gel of the gel pad has a water content of less than 15% by weight.
16. The medical dressing configured to be applied on intact skin and configured to prevent an onset of a pressure ulcer during use according to claim 1 , wherein the medical dressing consists of the backing layer, the gel pad, and the adhesive body contact layer.
17. The medical dressing configured to be applied on intact skin and configured to prevent an onset of a pressure ulcer during use according to claim 1 , wherein the adhesive body contact layer extends beyond the periphery of the gel pad and is coextensive with the backing layer to define the border portion around the contour of the gel pad.
18. The medical dressing configured to be applied on intact skin and configured to prevent an onset of a pressure ulcer during use according to claim 1 , wherein the backing layer comprises the second opposing side of the medical dressing.
19. The medical dressing configured to be applied on intact skin and configured to prevent an onset of a pressure ulcer during use according to claim 1 , wherein an entire area of the adhesive body contact layer is configured to adhere to the dermal surface during use.
20. The medical dressing configured to be applied on intact skin and configured to prevent an onset of a pressure ulcer during use according to claim 1 , wherein the gel pad and the adhesive body contact layer are configured to allow the caregiver to perform the blanching test through the medical dressing of an entire area of the subject covered by the gel pad during use, wherein the adhesive body contact layer is configured to adhere to the dermal surface over the entire area during use.
21. The medical dressing configured to be applied on intact skin and configured to prevent an onset of a pressure ulcer during use according to claim 1 , wherein the adhesive body contact layer covers at least 60% of a surface area of the gel pad.